Search

everythinglearnresearchcommunity

for

Search:↓

IL16 gene variations may affect the risk of alopecia areata in Koreans.

Anti-CD19 therapy may help treat SLE and NMOSD.

New findings suggest potential treatments for melanoma, hyperpigmentation, hair defects, and multiple sclerosis, and show skin microbiome changes don't cause atopic dermatitis.

A new model helps study acne and test treatments.

Different immune responses cause hair loss in scalp diseases, with unique patterns in scalp psoriasis possibly protecting against hair loss.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Scientists made a mouse model of a serious skin cancer by changing skin cells with a virus and a specific gene, which is similar to the disease in humans.

CXCR2 in skin cells promotes tumor growth.

Combining MMP-9 and JAK inhibitors can effectively prevent skin depigmentation in vitiligo.

NKIRAS2 can suppress certain skin tumors but its effect on cancer varies with context and expression level.

Innate lymphoid cells type 1 may contribute to alopecia areata.

Psoriasis patients have immune cells that respond more strongly to signals and stimuli due to an intrinsic cellular defect.

Enterococcus faecalis delays wound healing by disrupting cell functions and creating an anti-inflammatory environment.

Loss of a specific protein in skin cells causes symptoms similar to psoriasis.

CRET therapy affects inflammation in skin cells by changing cytokine levels and activating certain proteins.

Wasabi leaf extract affects gene expression in skin cells.

Targeting mTOR in myeloid cells may help reduce psoriasis symptoms.

Telitacicept effectively improved hair regrowth in a woman with lupus and alopecia.

Unconventional lymphocytes are important for quick immune responses and healing of skin and mucosal barriers.

MSC-CM cream speeds up burn wound healing better than the control treatment.

A parasite-derived molecule speeds up skin healing and affects immune cell behavior without increasing scarring.

Revertant cell therapy shows promise for treating type XVII collagen deficiency, but better cell selection methods are needed.

Targeting TCR-Vβ2 in cutaneous T cell lymphoma shows promise for safer, more specific treatment.

DHT may reduce inflammation caused by certain bacteria in skin cells.

Blocking TGFβ-RI signaling enhances surface ectoderm differentiation from human stem cells.

COX-2 and Bcl-2 proteins are involved in Lichen Planus.

Protein kinase C epsilon may promote skin cancer development after UV exposure by affecting nearby cells.